Loading clinical trials...
Loading clinical trials...
Comparison Of Mobilization With Movement And Soft Tissue Mobilization On Pain Severity , Hand Grip Strength And Functional Activity Tennis Elbow Patients.
Lateral epicondylitis or tennis elbow is one of the most common lesions of the arm. This injury is a major challenge, as it is difficult to treat, prone to recurrence and may last for several weeks or months, with an average duration of a typical episode which has been reported to be between six months to two years. This is an RCT study. Subjects who fulfilled inclusion criteria will be taken for the study. Before conducting the actual method for subjects, lateral epicondylitis evaluation is done. First day before treatment, pain evaluation were done by using Numeric Pain Rating Scale. Muscle power was assessed by MMT (Manual Muscle Testing) and the function level are tested by Patient-Related Tennis Elbow Evaluation (PRTEE) questionnaire and asked to mark the results. Subjects will be divided into 2 groups randomly by lottery method. Each group consists of 15 patients. Group A will be given MWM; Group B will be given soft tissue mobilization. Both groups will be given with the above said methods for alternative days in a week as per 3 sessions per week for 4 weeks. At the end of program subjects will be reassessed by recording muscle strength, pain intensity and functional level. Finally pre and post recordings will be compared and analyzed statistically.
Age
15 - 30 years
Sex
ALL
Healthy Volunteers
No
Hidayat Gillani Orthopedic Complex Sahiwal
Sahiwal, Punjab Province, Pakistan
Start Date
October 14, 2020
Primary Completion Date
June 30, 2021
Completion Date
July 15, 2021
Last Updated
September 10, 2021
30
ACTUAL participants
Mobilization with movement
OTHER
Soft Tissue Mobilization
OTHER
Lead Sponsor
Riphah International University
NCT07314840
NCT07178288
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions